On 14 February 2022, Xlife Sciences successfully listed its shares on the standard “Sparks” of SIX Swiss Exchange — making it the very first listing on the new and regulated SME segment of SIX Swiss Exchange. Xlife Sciences focuses on the value development and commercialization of promising early-stage research projects from universities and other research institutions in the life sciences industry.
CapLaw Themes
- FinSA (FIDLEG) (32)
- FinIA (FINIG) (11)
- Insurance (8)
- Securities (92)
- Regulatory (128)
- Takeover (19)
- Derivatives (7)
- News, Deals & Cases (450)
- Events (149)
- Other Areas (8)
CapLaw PDF Archive
Discover more articles
We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.